Drug Profile
Research programme: anti-infective therapies - Wyeth
Alternative Names: Hap5Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Haptogen
- Developer Pfizer
- Class Monoclonal antibodies
- Mechanism of Action Signal transduction pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in Scotland (IV)
- 14 Dec 2005 Preclinical trials in Bacterial infections in Scotland (unspecified route)